Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for Niagen Bioscience (NAGE) over the last 1 years, with Sep 2025 value amounting to 0.28%.

  • Niagen Bioscience's Return on Invested Capital was N/A to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year change of. This contributed to the annual value of 0.20% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Return on Invested Capital is 0.28%, which was up 2.03% from 0.27% recorded in Q2 2025.
  • Niagen Bioscience's 5-year Return on Invested Capital high stood at 0.28% for Q3 2025, and its period low was 0.19% during Q4 2024.
  • Over the past 2 years, Niagen Bioscience's median Return on Invested Capital value was 0.26% (recorded in 2025), while the average stood at 0.25%.